Back to Search
LLOYD CANTLEY, MD
MD
Nephrology Physician
NPI: 1578549366IndividualAccepts Medicare
Specialties, Licenses & Credentials
Nephrology PhysicianPrimary
Internal Medicine — Nephrology
Code: 207RN0300X
038582(CT)
CMS Specialties
PrimaryNEPHROLOGY
Education
WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE
Class of 1981
Research & Publications (20)
Neutrophil gelatinase-associated lipocalin suppresses cyst growth by Pkd1 null cells in vitro and in vivo.
PMID 18974761·Kidney Int·2008
7-preclinical
Adult stem cells in the repair of the injured renal tubule.
PMID 16932361·Nat Clin Pract Nephrol·2005
6-review
Hepatocyte growth factor induces MAPK-dependent formin IV translocation in renal epithelial cells.
PMID 11095644·J Am Soc Nephrol·2000
7-preclinical
Searching for genes that matter in acute kidney injury: a systematic review.
PMID 19443624·Clin J Am Soc Nephrol·2009
1-meta
Understanding the Warburg effect: the metabolic requirements of cell proliferation.
PMID 19460998·Science·2009
6-review
Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation.
PMID 19481526·Mol Cell·2009
7-preclinical
Deletion of the Met receptor in the collecting duct decreases renal repair following ureteral obstruction.
PMID 19675527·Kidney Int·2009
7-preclinical
PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer.
PMID 19237633·J Clin Oncol·2009
8-other
The antiproliferative cytostatic effects of a self-activating viridin prodrug.
PMID 19509266·Mol Cancer Ther·2009
7-preclinical
Bidirectional transport of amino acids regulates mTOR and autophagy.
PMID 19203585·Cell·2009
7-preclinical
Met and the epidermal growth factor receptor act cooperatively to regulate final nephron number and maintain collecting duct morphology.
PMID 19103805·Development·2009
7-preclinical
Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation.
PMID 19187764·Mol Cell·2009
7-preclinical
Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling.
PMID 19647222·Cancer Cell·2009
8-other
Sex differences in injury patterns among workers in heavy manufacturing.
PMID 18996885·Am J Epidemiol·2009
4-observational
Biomolecular characterization and protein sequences of the Campanian hadrosaur B. canadensis.
PMID 19407199·Science·2009
7-preclinical
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers.
PMID 19029981·Nat Med·2008
7-preclinical
Zag expression during aging suppresses proliferation after kidney injury.
PMID 18815245·J Am Soc Nephrol·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 800 HOWARD AVENUE, YALE PHYSICIANS BUILDING
NEW HAVEN, CT 06519 - Phone
- (203) 785-2140
Quick Facts
- NPI
- 1578549366
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 45
- Publications
- 20
Are you this provider?
Claim Your Profile